NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
NGFR | Nerve growth factor receptor | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
PAK1 | P21 protein (Cdc42/Rac)-activated kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PAK2 | P21 protein (Cdc42/Rac)-activated kinase 2 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PAK4 | P21 protein (Cdc42/Rac)-activated kinase 4 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PDGFB | Platelet-derived growth factor beta polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PDGFC | Platelet derived growth factor C | Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PIK3CD | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PLA2G12A | Phospholipase A2, group XIIA | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
PLA2G1B | Phospholipase A2, group IB (pancreas) | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
PLA2G4A | Phospholipase A2, group IVA (cytosolic, calcium-dependent) | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
PLA2G4E | Phospholipase A2, group IVE | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enriched |
PLCE1 | Phospholipase C, epsilon 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
PLCG1 | Phospholipase C, gamma 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PLCG2 | Phospholipase C, gamma 2 (phosphatidylinositol-specific) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLD1 | Phospholipase D1, phosphatidylcholine-specific | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PRKACA | Protein kinase, cAMP-dependent, catalytic, alpha | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKACB | Protein kinase, cAMP-dependent, catalytic, beta | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKCG | Protein kinase C, gamma | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enriched |
PRKX | Protein kinase, X-linked | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RAB5B | RAB5B, member RAS oncogene family | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
RAB5C | RAB5C, member RAS oncogene family | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
RASA2 | RAS p21 protein activator 2 | Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
RASAL1 | RAS protein activator like 1 (GAP1 like) | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RASAL3 | RAS protein activator like 3 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
RASGRF2 | Ras protein-specific guanine nucleotide-releasing factor 2 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
RELA | V-rel avian reticuloendotheliosis viral oncogene homolog A | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
RGL1 | Ral guanine nucleotide dissociation stimulator-like 1 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
RHOA | Ras homolog family member A | Cancer-related genes Cytoskeleton related proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
RRAS2 | Related RAS viral (r-ras) oncogene homolog 2 | Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | Mitochondrial proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
SOS2 | Son of sevenless homolog 2 (Drosophila) | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
STK4 | Serine/threonine kinase 4 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
VEGFA | Vascular endothelial growth factor A | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
ZAP70 | Zeta-chain (TCR) associated protein kinase 70kDa | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |